Re-I Chin1, Yuan James Rao1, Michael Y Hwang2, Christopher R Spencer1, Michael Pierro3, Todd DeWees1, Pranav Patel4, Parul Sinha5, Hiram A Gay1, Mackenzie Daly1, Bruce H Haughey6, Brian Nussenbaum5, Douglas R Adkins7, James S Lewis8, Wade L Thorstad1. 1. Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri. 2. Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. 3. Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. 4. Department of Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland. 5. Division of Head and Neck Surgery, Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri. 6. Head and Neck Surgery, Florida Hospital Celebration Health, Celebration, Florida. 7. Division of Hematology and Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri. 8. Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee.
Abstract
BACKGROUND: The authors hypothesized that unilateral intensity-modulated radiotherapy (IMRT) would decrease toxicity compared with bilateral IMRT for patients with lateralized palatine tonsillar cancer and a neck classification of N0 to N2b, with similar oncological outcomes. METHODS: A total of 154 patients were treated with postoperative IMRT from 1997 through 2013. Data were collected prospectively from 2005 to 2013 and retrospectively collected before 2005. Of those patients with lateralized primary and N0 to N2b disease, 48 received unilateral IMRT (group 1) and 59 received bilateral IMRT (group 2); a total of 47 patients had nonlateralized primary or N2c to N3 disease and received bilateral IMRT (group 3). RESULTS: The median follow-up was 5.5 years. The 5-year locoregional control rates were similar in group 1, group 2, and group 3 (100%, 96%, and 94%, respectively; pooled comparison: P = .39 and group 1 vs group 2 comparison: P = .19). The 5-year overall survival rates were similar in group 1, group 2, and group 3 (85%, 79%, and 76%, respectively; pooled comparison: P = .60 and group 1 vs group 2 comparison: P = .25). There were no contralateral neck recurrences noted among unilaterally treated patients. Unilateral IMRT reduced acute toxicity and improved patient-reported quality of life compared with bilateral IMRT. CONCLUSIONS: Unilateral IMRT appears to reduce acute toxicity and achieves oncological outcomes similar to those of bilateral IMRT in selected patients with lateralized palatine tonsillar cancer with a neck classification of N0 to N2b. Cancer 2017;123:4594-4607.
BACKGROUND: The authors hypothesized that unilateral intensity-modulated radiotherapy (IMRT) would decrease toxicity compared with bilateral IMRT for patients with lateralized palatine tonsillar cancer and a neck classification of N0 to N2b, with similar oncological outcomes. METHODS: A total of 154 patients were treated with postoperative IMRT from 1997 through 2013. Data were collected prospectively from 2005 to 2013 and retrospectively collected before 2005. Of those patients with lateralized primary and N0 to N2b disease, 48 received unilateral IMRT (group 1) and 59 received bilateral IMRT (group 2); a total of 47 patients had nonlateralized primary or N2c to N3 disease and received bilateral IMRT (group 3). RESULTS: The median follow-up was 5.5 years. The 5-year locoregional control rates were similar in group 1, group 2, and group 3 (100%, 96%, and 94%, respectively; pooled comparison: P = .39 and group 1 vs group 2 comparison: P = .19). The 5-year overall survival rates were similar in group 1, group 2, and group 3 (85%, 79%, and 76%, respectively; pooled comparison: P = .60 and group 1 vs group 2 comparison: P = .25). There were no contralateral neck recurrences noted among unilaterally treated patients. Unilateral IMRT reduced acute toxicity and improved patient-reported quality of life compared with bilateral IMRT. CONCLUSIONS: Unilateral IMRT appears to reduce acute toxicity and achieves oncological outcomes similar to those of bilateral IMRT in selected patients with lateralized palatine tonsillar cancer with a neck classification of N0 to N2b. Cancer 2017;123:4594-4607.
Authors: Aisling S Last; Patrik Pipkorn; Stephanie Chen; Dorina Kallogjeri; Joseph Zenga; Jason T Rich; Randal Paniello; Jose Zevallos; Rebecca Chernock; Douglas Adkins; Peter Oppelt; Hiram Gay; Mackenzie Daly; Wade Thorstad; Ryan S Jackson Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-01-01 Impact factor: 6.223
Authors: Nicolette Taku; Gregory Chronowski; G Brandon Gunn; William H Morrison; Neil D Gross; Amy C Moreno; Renata Ferrarotto; Steven J Frank; C David Fuller; Ryan P Goepfert; Jack Phan; Stephen Y Lai; Jay P Reddy; David I Rosenthal; Adam S Garden Journal: Int J Radiat Oncol Biol Phys Date: 2022-05-02 Impact factor: 8.013
Authors: Alexander J Lin; Margery Gang; Yuan James Rao; Jian Campian; Mackenzie Daly; Hiram Gay; Peter Oppelt; Ryan S Jackson; Jason Rich; Randal Paniello; Jose Zevallos; Dennis Hallahan; Douglas Adkins; Wade Thorstad Journal: JAMA Otolaryngol Head Neck Surg Date: 2019-05-01 Impact factor: 6.223
Authors: Jared Gershowitz; Hann-Hsiang Chao; Abigail Doucette; John N Lukens; Samuel Swisher-McClure; Gregory S Weinstein; Bert W O'Malley; Ara A Chalian; Christopher H Rassekh; Jason G Newman; Roger B Cohen; Joshua M Bauml; Charu Aggarwal; Alexander Lin Journal: Br J Radiol Date: 2019-10-15 Impact factor: 3.039
Authors: Sonja Stieb; Ismael Perez-Martinez; Abdallah S R Mohamed; Stockton Rock; Nimit Bajaj; Tanaya S Deshpande; Mohamed Zaid; Adam S Garden; Ryan P Goepfert; Richard Cardoso; Renata Ferrarotto; Jay P Reddy; Jack Phan; William H Morrison; David I Rosenthal; Eugene J Koay; Steven J Frank; C David Fuller; G Brandon Gunn Journal: Clin Transl Radiat Oncol Date: 2020-06-09
Authors: Pencilla Lang; Jessika Contreras; Noah Kalman; Claire Paterson; Houda Bahig; Astrid Billfalk-Kelly; Sinead Brennan; Kathy Rock; Nancy Read; Varagur Venkatesan; Jinka Sathya; Lucas C Mendez; S Danielle MacNeil; Anthony C Nichols; Kevin Fung; Adrian Mendez; Eric Winquist; Sara Kuruvilla; Paul Stewart; Andrew Warner; Sylvia Mitchell; Julie A Theurer; David A Palma Journal: Radiat Oncol Date: 2020-08-14 Impact factor: 3.481